NCT04643106 Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function
| NCT ID | NCT04643106 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Benign Ovarian Cyst |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2021-02-25 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2021-02-25 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.
Eligibility Criteria
Inclusion Criteria: * Informed consent. * Age: 19-45 year-old women * American Society of Anesthesiologists Physical Status classification 1 or 2 * Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography * Regular menstruation every 21-45 days Exclusion Criteria: * No 'ovarian' endometriosis * Suspicious disease of ovarian malignancy * Age: 18 and younger, 46 and older * Pregnancy or breastfeeding. * Lower than 0.05 ng/ml of serum Anti-mullerian hormone level * Hormonal therapy within recent 3 months * Considered as inappropriate by the researcher's judgment.
Contact & Investigator
Hee seung Kim, MD/PhD
PRINCIPAL INVESTIGATOR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT04643106 clinical trial?
This trial is open to female participants only, aged 19 Years or older, up to 45 Years, studying Benign Ovarian Cyst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04643106 currently recruiting?
Yes, NCT04643106 is actively recruiting participants. Contact the research team at hyunji3292@gmail.com for enrollment information.
Where is the NCT04643106 trial being conducted?
This trial is being conducted at Goyang-si, South Korea, Seoul, South Korea.
Who is sponsoring the NCT04643106 clinical trial?
NCT04643106 is sponsored by Seoul National University Hospital. The principal investigator is Hee seung Kim, MD/PhD at Seoul National University Hospital. The trial plans to enroll 90 participants.